|
End-of-day quote
Korea S.E.
2026-09-10
|
5-day change | 1st Jan Change | ||
| 53,100.00 KRW | -1.30% |
|
-2.57% | -55.75% |
| 08-22 | Orum Therapeutics Receives FDA Clearance Of IND Application For ORM-1153, A Novel CD123-GSPT1 Degrader-Antibody Conjugate | CI |
| 07-15 | Alert wrongly tagged to Orum Therapeutics withdrawn | RE |
Chart: Technical Analysis
Korea S.E.KRW
| Markets | Quality | ||
|---|---|---|---|
Korea S.E.
| A475830 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 72,500 | 139,500 | 143,700 |
| Spread/Res. | -26.76% | -61.94% | -63.05% |
| Spread/Supp. | +7.71% | +40.48% | +65.16% |
| Support | 49,300 | 37,800 | 32,150 |
- Stock Market
- Stocks
- A475830 Stock
- Charts Orum Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
